Oncology Analytics, Inc.
Oncology Analytics, Inc., commonly referred to as Oncology Analytics, is a leading provider of advanced analytics and technology solutions in the oncology sector. Headquartered in the United States, the company operates across major regions, delivering innovative services to healthcare providers and payers. Founded in 2014, Oncology Analytics has achieved significant milestones, including the development of proprietary tools that enhance clinical decision-making and improve patient outcomes. The company’s core offerings include data-driven insights, treatment optimisation, and cost management solutions tailored specifically for oncology. What sets Oncology Analytics apart is its commitment to integrating clinical expertise with cutting-edge technology, ensuring that healthcare professionals have access to the most relevant information. With a strong market position, Oncology Analytics continues to be recognised for its contributions to improving cancer care and driving efficiencies within the healthcare system.
DitchCarbon Score
How does Oncology Analytics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Oncology Analytics, Inc.'s score of 31 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Oncology Analytics, Inc.'s reported carbon emissions
In 2023, Oncology Analytics, Inc. reported total carbon emissions of approximately 6,800,000,000 kg CO2e across all scopes. This figure includes 113,528,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 139,701,000 kg CO2e from Scope 2 emissions, which are indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Notably, Scope 3 emissions, which encompass all other indirect emissions in the value chain, remained constant at about 6,800,000,000 kg CO2e. In comparison, the previous year, 2022, saw total emissions of approximately 6,800,000,000 kg CO2e, with Scope 1 emissions at 118,000,000 kg CO2e and Scope 2 emissions at 171,000,000 kg CO2e. This indicates a slight reduction in Scope 1 and Scope 2 emissions in 2023. Despite these figures, Oncology Analytics, Inc. has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or science-based targets suggests that the company may still be in the early stages of formalising its climate commitments. As the industry increasingly prioritises sustainability, Oncology Analytics, Inc. may need to develop and communicate clear strategies to address its carbon emissions effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 118,000,000 | 000,000,000 |
| Scope 2 | 171,000,000 | 000,000,000 |
| Scope 3 | 6,800,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Oncology Analytics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
